Results 21 to 30 of about 26,693 (188)

Health Risks, Past Usage, and Intention to Use Weight Loss Products in Normal Weight Women with High and Low Body Dysphoria [PDF]

open access: yes, 2003
Objective: There are many health risks involved with the use of weight loss products by normal weight women. The mass media may compound this problem through the promotion of weight loss products and a thin body size.
Andrews, J. Craig   +3 more
core   +3 more sources

Differences in self-reported weekend catch up sleep between children and adolescents with and without primary hypertension

open access: yesClinical Hypertension, 2018
Background The data on the association of sleep duration and blood pressure in the pediatric age group have been mixed and most studies have focused on weekday sleep duration.
Neena Gupta   +2 more
doaj   +1 more source

Insomnia and emotion regulation. Recent findings and suggestions for treatment [PDF]

open access: yes, 2015
Recent findings suggest that insomnia and emotion regulation are closely connected. Insomnia is widely associated with medical and psychiatric conditions as well as with impaired quality of life and emotional functioning.
BALLESIO, ANDREA   +2 more
core   +1 more source

Risk Factor Profile in Parkinson’s Disease Subtype with REM Sleep Behavior Disorder

open access: yesJournal of Parkinson’s Disease, 2016
Background: Numerous large-scale studies have found diverse risk factors for Parkinson’s disease (PD), including caffeine non-use, non-smoking, head injury, pesticide exposure, and family history.
Marie L. Jacobs   +8 more
doaj   +1 more source

The relationship between the Keirsey Temperament Sorter and the short-form Revised Eysenck Personality Questionnaire [PDF]

open access: yes, 2008
The two models of personality proposed by the Keirsey Temperament Sorter (KTS) and by the short-form Revised Eysenck Personality Questionnaire (EPQR-S) both propose measures of extraversion-introversion, but in other respects the two models are quite ...
Craig, Charlotte L.   +2 more
core   +1 more source

Genetic and Pathological Testing Attitudes for Parkinson's Disease in At‐Risk Relatives

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Parkinson's disease (PD) is increasingly recognized as a neurodegenerative disorder with a broad clinical spectrum and diverse biomarkers enabling early detection. α‐synuclein seed amplification assays (SAA) and genetic testing now allow identification of PD pathology in asymptomatic individuals.
Tal Weil   +5 more
wiley   +1 more source

The caffeine dilemma: unraveling the intricate relationship between caffeine use disorder, caffeine withdrawal symptoms and mental well-being in adults

open access: yesPublic Health Nutrition
Objective: This study aimed to explore the relationship between caffeine use disorder (CUD), caffeine withdrawal symptoms and the prevalence of depression, anxiety and stress (DASS) in adults.
Mahmut Bodur   +4 more
doaj   +1 more source

Yoga for generalized anxiety disorder: design of a randomized controlled clinical trial. [PDF]

open access: yes, 2015
Generalized anxiety disorder (GAD) is a common disorder associated with significant distress and interference. Although cognitive behavioral therapy (CBT) has been shown to be the most effective form of psychotherapy, few patients receive or have access ...
Bui, Eric   +7 more
core   +1 more source

Revisiting the Association of Pesticide Exposure and Parkinson's Disease: Systematic Review and Meta‐Analysis

open access: yesEnvironmental Toxicology, EarlyView.
ABSTRACT The association between pesticide exposure and Parkinson's disease (PD) is substantial, but heterogeneity in methodology and lack of categorization according to the type of exposure and pesticide classes in previous meta‐analyses impair the interpretation of data. This study aims to update evidence of the association between pesticide exposure
Pedro Henrique Passos da Silva   +6 more
wiley   +1 more source

5‐Methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT) for alcohol use disorder: An open‐label, phase 2, proof‐of‐concept, clinical trial

open access: yesAddiction, EarlyView.
Abstract Background and Aims Psychedelic drugs may help treat alcohol use disorder (AUD). This study evaluated BPL‐003, a novel intranasal powder formulation of 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT) benzoate salt, in people with moderate–severe AUD enrolled in a standard of care, 10‐week programme of relapse‐prevention oriented Cognitive ...
John Marsden   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy